4//SEC Filing
MUTO FREDERICK T 4
Accession 0000874015-19-000065
CIK 0000874015other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 6:16 PM ET
Size
10.2 KB
Accession
0000874015-19-000065
Insider Transaction Report
Form 4
MUTO FREDERICK T
Director
Transactions
- Sale
Common Stock
2019-05-06$72.75/sh−8,000$582,002→ 9,794 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-06+8,000→ 0 totalExercise: $24.42From: 2018-07-01Exp: 2026-06-30→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2019-05-06$24.42/sh+8,000$195,360→ 17,794 total
Holdings
- 1,500(indirect: By Cooley LLP Sal Def & PSP u/A DTD 2/1/74 Pension Plan)
Common Stock
Footnotes (2)
- [F1]Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 4/4/2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.60 to $72.92, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001181560
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 6:16 PM ET
- Size
- 10.2 KB